SPONSOR
Alimentiv Inc.
Total Trials
3
Recruiting
3
Phases
Phase 4
Conditions studied: Crohn's DiseaseModerately to Severely Active Crohn's DiseaseCrohn DiseaseDisease CrohnCrohn Disease (CD)
Alimentiv Inc. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Crohn's Disease, Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Alimentiv Inc.
How many clinical trials has Alimentiv Inc. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Alimentiv Inc., of which 3 are actively recruiting participants. These trials cover conditions including Crohn's Disease, Moderately to Severely Active Crohn's Disease, Crohn Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Alimentiv Inc. research focus on?
Alimentiv Inc. clinical trials span Crohn's Disease, Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn, Crohn Disease (CD). The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Alimentiv Inc. clinical trial?
To participate in a Alimentiv Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Alimentiv Inc. trials with current recruitment status updated daily.
Clinical Trials by Alimentiv Inc.
NCT06249555
Recruiting
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
Crohn's Disease
NCT06257706 Phase 4
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Moderately to Severely Active Crohn's Disease
NCT07363044
Recruiting
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease
Crohn Disease (CD)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology